Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients

Abstract Circulating tumor cells (CTC) are prognostic in metastatic breast cancer (MBC). The CTC-endocrine therapy index (CTC-ETI), consisting of CTC-ER (estrogen receptor), BCL2, human epidermal growth factor receptor (HER2), and Ki67 expression, might predict resistance to endocrine therapy (ET) i...

Description complète

Détails bibliographiques

Auteurs principaux:	Costanza Paoletti, Meredith M. Regan, Samuel M. Niman, Emily M. Dolce, Elizabeth P. Darga, Minetta C. Liu, P. Kelly Marcom, Lowell L. Hart, John W. Smith, Karen L. Tedesco, Eitan Amir, Ian E. Krop, Angela M. DeMichele, Pamela J. Goodwin, Margaret Block, Kimberly Aung, Martha E. Brown, Robert T. McCormack, Daniel F. Hayes
Format:	Artigo
Langue:	Inglês
Publié:	Nature Portfolio 2021-06-01
Collection:	npj Breast Cancer
Accès en ligne:	https://doi.org/10.1038/s41523-021-00281-1
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!